Th17 cells are increased with severity of liver inflammation in patients with chronic hepatitis C

Journal of Gastroenterology and Hepatology (Australia)

Volumn 27, Issue 2, 2012, Pages 273-278

  Chang, Qing ^a   Wang, Yan Kun ^b   Zhao, Qing ^a   Wang, Chang Zheng ^a   Hu, Ya Zhuo ^a   Wu, Ben Yan ^a  

^a CHINESE PLA GENERAL HOSPITAL   (China)

^b MEDICAL COLLEGE OF CHINESE PEOPLE'S ARMED POLICE FORCES   (China)

Author keywords

Hepatitis; Hepatitis C virus; Interleukin 17; T cells

Indexed keywords

INTERLEUKIN 17;

ARTICLE; CELL FUNCTION; CELL INFILTRATION; CONTROLLED STUDY; CORRELATION ANALYSIS; DISEASE COURSE; DISEASE SEVERITY; HEPATITIS C; HEPATITIS C VIRUS; HUMAN; HUMAN CELL; HUMAN TISSUE; LIVER INJURY; LYMPHOCYTE; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; TH17 CELL; VIRUS REPLICATION;

EID: 84862908233     PISSN: 08159319     EISSN: 14401746     Source Type: Journal    
DOI: 10.1111/j.1440-1746.2011.06782.x     Document Type: Article

References (36)

1. Dienstag JL, McHutchison JG. American Gastroenterological Association technical review on the management of hepatitis C. Gastroenterology 2006; 130: 231-64.
2. Rehermann B, Nascimbeni M. Immunology of hepatitis B virus and hepatitis C virus infection. Nat. Rev. Immunol. 2005; 5: 215-29.
3. Liang TJ, Rehermann B, Seeff LB etal. Pathogenesis, natural history, treatment, and prevention of hepatitis C. Ann. Intern. Med. 2000; 132: 296-305.
4. Davis GL, Albright JE, Cook SF etal. Projecting future complications of chronic hepatitis C in the United States. Liver Transpl. 2003; 9: 331-8.
5. Grakoui A, Shoukry NH, Woollard DJ etal. HCV persistence and immune evasion in the absence of memory T cell help. Science 2003; 302: 659-62.
6. + T cells are required for protection from persistent hepatitis C virus infection. J. Exp. Med. 2003; 197: 1645-55.
7. Chang KM. Immunopathogenesis of hepatitis C virus infection. Clin. Liver Dis. 2003; 7: 89-105.
8. Takaki A, Wiese M, Maertens G etal. Cellular immune responses persist and humoral responses decrease two decades after recovery from a single-source outbreak of hepatitis C. Nat. Med. 2000; 6: 578-82.
9. Ulsenheimer A, Gerlach JT, Gruener NH etal. Detection of functionally altered hepatitis C virus-specific CD4 T cells in acute and chronic hepatitis C. Hepatology 2003; 37: 1189-98.
10. Yao ZQ, Nguyen DT, Hiotellis AI etal. Hepatitis C virus core protein inhibits human T lymphocyte responses by a complement-dependent regulatory pathway. J. Immunol. 2001; 167: 5264-72.
11. Ge J, Wang K, Meng QH etal. Implication of Th17 and Th1 cells in patients with chronic active hepatitis B. J. Clin. Immunol. 2010; 30: 60-7.
12. Ye Y, Xie X, Yu J etal. Involvement of Th17 and Th1 effector responses in patients with Hepatitis B. J. Clin. Immunol. 2010; 30: 546-55.
13. Wu W, Li J, Chen F etal. Circulating Th17 cells frequency is associated with the disease progression in HBV infected patients. J. Gastroenterol. Hepatol. 2010; 25: 750-7.
14. Zhang JY, Zhang Z, Lin F etal. Interleukin-17-producing CD4(+) T cells increase with severity of liver damage in patients with chronic hepatitis B. Hepatology 2010; 51: 81-91.
15. Ouyang W, Kolls JK, Zheng Y. The biological functions of T helper 17 cell effector cytokines in inflammation. Immunity 2008; 28: 454-67.
16. Dong C. TH17 cells in development: an updated view of their molecular identity and genetic programming. Nat. Rev. Immunol. 2008; 8: 337-48.
17. Park H, Li Z, Yang XO etal. A distinct lineage of CD4 T cells regulates tissue inflammation by producing interleukin 17. Nat. Immunol. 2005; 6: 1133-41.
18. + T helper cells. Cell 2006; 126: 1121-33.
19. van Beelen AJ, Teunissen MB, Kapsenberg ML etal. Interleukin-17 in inflammatory skin disorders. Curr. Opin. Allergy Clin. Immunol. 2007; 7: 374-81.
20. Tesmer LA, Lundy SK, Sarkar S etal. Th17 cells in human disease. Immunol. Rev. 2008; 223: 87-113.
21. Hohl TM, Rivera A, Pamer EG. Immunity to fungi. Curr. Opin. Immunol. 2006; 18: 465-72.
22. Korn T, Bettelli E, Oukka M etal. IL-17 and Th17 Cells. Annu. Rev. Immunol. 2009; 27: 485-517.
23. Mills KH. Induction, function and regulation of IL-17-producing T cells. Eur. J. Immunol. 2008; 38: 2636-49.
24. Lemmers A, Moreno C, Gustot T etal. The interleukin-17 pathway is involved in human alcoholic liver disease. Hepatology 2009; 49: 646-57.
25. Kuang DM, Peng C, Zhao Q etal. Activated monocytes in peritumoral stroma of hepatocellular carcinoma promote expansion of memory T helper 17 cells. Hepatology 2010; 51: 154-64.
26. Zhang JP, Yan J, Xu J etal. Increased intratumoral IL-17-producing cells correlate with poor survival in hepatocellular carcinoma patients. J. Hepatol. 2009; 50: 980-9.
27. Lan RY, Salunga TL, Tsuneyama K etal. Hepatic IL-17 responses in human and murine primary biliary cirrhosis. J. Autoimmun. 2009; 32: 43-51.
28. Yang Z, Zhang B, Li D etal. Mast cells mobilize myeloid-derived suppressor cells and Treg cells in tumor microenvironment via IL-17 pathway in murine hepatocarcinoma model. PLoS ONE 2010; 5: e8922.
29. Yasumi Y, Takikawa Y, Endo R etal. Interleukin-17 as a new marker of severity of acute hepatic injury. Hepatol. Res. 2007; 37: 248-54.
30. Rong G, Zhou Y, Xiong Y etal. Imbalance between T helper type 17 and T regulatory cells in patients with primary biliary cirrhosis: the serum cytokine profile and peripheral cell population. Clin. Exp. Immunol. 2009; 156: 217-25.
31. Rowan AG, Fletcher JM, Ryan EJ etal. Hepatitis C virus-specific Th17 cells are suppressed by virus-induced TGF-beta. J. Immunol. 2008; 181: 4485-94.
32. Korn T, Bettelli E, Oukka M etal. IL-17 and Th17 Cells. Annu. Rev. Immunol. 2009; 27: 485-517.
33. Harada K, Shimoda S, Sato Y etal. Periductal interleukin-17 production in association with biliary innate immunity contributes to the pathogenesis of cholangiopathy in primary biliary cirrhosis. Clin. Exp. Immunol. 2009; 157: 261-70.
34. Pene J, Chevalier S, Preisser L etal. Chronically inflamed human tissues are infiltrated by highly differentiated Th17 lymphocytes. J. Immunol. 2008; 180: 7423-30.
35. Zhang L, Yang XQ, Cheng J etal. Increased Th17 cells are accompanied by FoxP3(+) Treg cell accumulation and correlated with psoriasis disease severity. Clin. Immunol. 2010; 135: 108-17.
36. Koenen HJ, Smeets RL, Vink PM etal. Human CD25highFoxp3pos regulatory T cells differentiate into IL-17-producing cells. Blood 2008; 112: 2340-52.